Part 1 - Welcome and Introduction - Dr. Shweta Surve, AstraZeneca
Part 2 - Introduction of guest speaker - Dr. M B Agarwal, Mumbai
Part 3 - Expert Opinion on RealWorld Challenges with BTK inhibitors in CLL Management - DrJohn Pagel
Part 4 - Case 1:Treatment naïve CLL - Dr. Kishore Kumar, Chennai
Part 5 - Case 2:Relapsed refractory CLL - Dr. Mukul Aggarwal, New Delhi
Part 6 - Case 3:High-risk CLL - Dr. Dharma Choudhary, New Delhi
Part 7 - panel discussion - Dr. Dharma Choudhary, New Delhi
Part 8 - Vote of thanks - Dr. Shweta Surve , AstraZeneca
